Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ionis Pharmaceuticals
Podcast
A pivotal time for an RNA pioneer
Ionis Pharmaceuticals is entering a busy stretch, with an FDA decision ahead and key phase 3 data expected this year.
Angus Liu
,
Ayla Ellison
May 1, 2026 8:30am
Ionis’ method to the Madness for Drug Name Tournament win
Apr 15, 2026 8:16am
Ionis slashes Tryngolza's price ahead of planned label expansion
Mar 25, 2026 2:59pm
Ionis ramps up Angelman syndrome awareness with Lifetime segment
Dec 17, 2025 12:23pm
Lilly, Otsuka and more earn nods from Europe's CHMP
Nov 14, 2025 11:52am
Ionis steps into crowded HAE market with FDA nod for Dawnzera
Aug 21, 2025 3:30pm
